Sökning: (swepub) lar1:(oru) pers:(Tysk Curt) conttype:(refereed) > Low-dose budesonide...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08963naa a2200805 4500 | |
001 | oai:DiVA.org:oru-47352 | |
003 | SwePub | |
008 | 160108s2016 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:ce882173-09fc-4163-9b30-2d40f1f2a5ce | |
009 | oai:prod.swepub.kib.ki.se:132594617 | |
009 | oai:DiVA.org:liu-112705 | |
009 | oai:DiVA.org:uu-274273 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-473522 URI |
024 | 7 | a https://doi.org/10.1136/gutjnl-2014-3083632 DOI |
024 | 7 | a https://lup.lub.lu.se/record/48159492 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1325946172 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1127052 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2742732 URI |
040 | a (SwePub)orud (SwePub)lud (SwePub)kid (SwePub)liud (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Münch, Andreasu Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för inflammationsmedicin,Hälsouniversitetet,Magtarmmedicinska kliniken,Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Gastroenterol & Hepatol, S-58185 Linkoping, Sweden.4 aut0 (Swepub:liu)andsa76 |
245 | 1 0 | a Low-dose budesonide for maintenance of clinical remission in collagenous colitis :b a randomised, placebo-controlled, 12-month trial |
264 | c 2014-11-25 | |
264 | 1 | b BMJ Publishing Group,c 2016 |
338 | a print2 rdacarrier | |
500 | a Funding Agency:Dr Falk Pharma GmbH, Freiburg, Germany | |
500 | a Funding agencies: Dr Falk Pharma GmbH, Freiburg, Germany | |
520 | a Objective: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis.Design: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically confirmed active collagenous colitis received budesonide (Budenofalk, 9 mg/day initially, tapered to 4.5 mg/day), after which 92 patients in clinical remission were randomised to budesonide (mean dose 4.5 mg/day; Budenofalk 3 mg capsules, two or one capsule on alternate days) or placebo in a 12-month double-blind phase with 6 months treatment-free follow-up. Primary endpoint was clinical remission throughout the double-blind phase.Results: Clinical remission during open-label treatment was achieved by 84.5% (93/110 patients). The median time to remission was 10.5 days (95% CI (9.0 to 14.0 days)). The maintenance of clinical remission at 1 year was achieved by 61.4% (27/44 patients) in the budesonide group versus 16.7% (8/48 patients) receiving placebo (treatment difference 44.5% in favour of budesonide; 95% CI (26.9% to 62.7%), p<0.001). Health-related quality of life was maintained during the 12-month double-blind phase in budesonide-treated patients. During treatment-free follow-up, 82.1% (23/28 patients) formerly receiving budesonide relapsed after study drug discontinuation. Low-dose budesonide over 1 year resulted in few suspected adverse drug reactions (7/44 patients), all non-serious.Conclusions: Budesonide at a mean dose of 4.5 mg/day maintained clinical remission for at least 1 year in the majority of patients with collagenous colitis and preserved health-related quality of life without safety concerns. Treatment extension with low-dose budesonide beyond 1 year may be beneficial given the high relapse rate after budesonide discontinuation. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
700 | 1 | a Bohr, Johan,d 1957-u Region Örebro län,Department of Gastroenterology, Örebro University Hospital, Örebro, Sweden,Örebro University Hospital, and School of Health and Medical Sciences, Örebro University, Sweden,Univ Orebro, Orebro Univ Hosp, Dept Gastroenterol, SE-70182 Orebro, Sweden.;Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.4 aut0 (Swepub:oru)jbr |
700 | 1 | a Miehlke, Stephanu Centre for Digestive Disease, Hamburg, Germany,Ctr Digest Dis, Hamburg, Germany.4 aut |
700 | 1 | a Benoni, Ceciliau Lund University,Lunds universitet,Anestesiologi och intensivvård,Forskargrupper vid Lunds universitet,Anaesthesiology and Intensive Care Medicine,Lund University Research Groups,University Hospital, Malmö, Sweden,Univ Hosp, Dept Gastroenterol, Malmo, Sweden.4 aut0 (Swepub:lu)medf-cbe |
700 | 1 | a Olesen, Martinu Department of Pathology, University Hospital, Malmö, Sweden,Univ Hosp, Dept Pathol, Malmo, Sweden.4 aut |
700 | 1 | a Öst, Åkeu Department of Pathology and Cytology, Aleris Medilab, Täby, Sweden,Aleris Medilab, Dept Pathol & Cytol, Taby, Sweden.4 aut |
700 | 1 | a Strandberg, Larsu Regional Hospital, Falun, Sweden,Reg Hosp, Falun, Sweden.4 aut |
700 | 1 | a Hellström, Per M.u Uppsala universitet,Gastroenterologi/hepatologi4 aut0 (Swepub:uu)perhe742 |
700 | 1 | a Hertervig, Eriku Lund University,Lunds universitet,Medicin, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,University Hospital, Lund, Sweden,Univ Lund Hosp, Dept Gastroenterol, S-22185 Lund, Sweden.4 aut0 (Swepub:lu)med-ehe |
700 | 1 | a Armerding, Peteru Gastroenterology, Private Practice, Berlin, Germany4 aut |
700 | 1 | a Stehlik, Jiriu Department of Gastroenterology, Regional Hospital, Usti nad Labem, Czech Republic,Reg Hosp, Dept Gastroenterol, Usti Nad Labem, Czech Republic.4 aut |
700 | 1 | a Lindberg, Gregeru Karolinska Institutet,Karolinska University Hospital Huddinge, Stockholm, Sweden,Karolinska Univ Hosp Huddinge, Ctr Digest Dis, Stockholm, Sweden.4 aut |
700 | 1 | a Björk, Janu Karolinska Institutet,Karolinska University Hospital Solna, Stockholm, Sweden,Karolinska Univ Hosp Solna, Ctr Digest Dis, Stockholm, Sweden.4 aut |
700 | 1 | a Lapidus, Annikau Department of Gastroenterology, Ersta Hospital, Stockholm, Sweden,Ersta Hosp, Dept Gastroenterol, Stockholm, Sweden.4 aut |
700 | 1 | a Löfberg, Robertu IBD Unit, Department of Gastroenterology, Sophiahemmet, Stockholm, Sweden,Sophiahemmet, Dept Gastroenterol, IBD Unit, Stockholm, Sweden.4 aut |
700 | 1 | a Bonderup, Oleu Department of Gastroenterology, Regional Hospital, Silkeborg, Denmark,Reg Hosp, Dept Gastroenterol, Silkeborg, Denmark.4 aut |
700 | 1 | a Avnström, Sörenu Department of Gastroenterology, Amager Hospital, Copenhagen, Denmark,Amager Hosp, Dept Gastroenterol, Copenhagen, Denmark.4 aut |
700 | 1 | a Rössle, Martinu Gastroenterology, Private Practice, Freiburg, Germany4 aut |
700 | 1 | a Dilger, Karinu Dr Falk, Pharma GmBH, Freiburg, Germany4 aut |
700 | 1 | a Mueller, Ralphu Dr Falk, Pharma GmBH, Freiburg, Germany4 aut |
700 | 1 | a Greinwald, Rolandu Dr Falk, Pharma GmBH, Freiburg, Germany4 aut |
700 | 1 | a Tysk, Curt,d 1949-u Region Örebro län,Department of Gastroenterology, Örebro University Hospital, Örebro, Sweden,Örebro University Hospital, and School of Health and Medical Sciences, Örebro University, Sweden,Univ Orebro, Orebro Univ Hosp, Dept Gastroenterol, SE-70182 Orebro, Sweden.;Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.4 aut0 (Swepub:oru)ctk |
700 | 1 | a Ström, Magnusu Linköpings universitet,Östergötlands Läns Landsting,Magtarmmedicinska kliniken,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Gastroenterol & Hepatol, S-58185 Linkoping, Sweden.4 aut0 (Swepub:liu)magst47 |
710 | 2 | a Linköpings universitetb Avdelningen för inflammationsmedicin4 org |
773 | 0 | t Gutd : BMJ Publishing Groupg 65:1, s. 47-56q 65:1<47-56x 0017-5749x 1468-3288 |
856 | 4 | u https://doi.org/10.1136/gutjnl-2014-308363y Fulltext |
856 | 4 | u https://gut.bmj.com/content/gutjnl/65/1/47.full.pdf |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/25425655?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1136/gutjnl-2014-308363y FULLTEXT |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:912697/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-47352 |
856 | 4 8 | u https://doi.org/10.1136/gutjnl-2014-308363 |
856 | 4 8 | u https://lup.lub.lu.se/record/4815949 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:132594617 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-112705 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-274273 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy